GlassScriptPhysician profile
Dinesh Jain
NPI 1003857103
$488.21
in general payments reported to CMS, 2019-2025
8 companies · $38.97 in 2025
The $38.97 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2022: $49.15 · 2023: $121 · 2024: $105 · 2025: $38.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $150.87 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $121.03 | 2023 | |
| Mauna Kea Technologies, INC. | $94.66 | 2019 | |
| Glaxosmithkline, LLC. | $54.13 | 2019 | |
| Braeburn INC. | $22.36 | 2025 | Brixadi |
| Kowa Pharmaceuticals America, INC. | $16.91 | 2022 | |
| Antares Pharma, INC. | $16.61 | 2025 | Xyosted |
| Takeda Pharmaceuticals U.S.A., INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dinesh Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.